We found 143 records for "Licensing / acquisition"

Articles

Selling science to potential investors and partners

12th September 2014

 Selling science to potential investors and partnersArticles

Start-ups and biotechs often need the support of outside investors to take their innovations to the next level. So what are the considerations when preparing a presentation for these important...

Read more

Adaptive Licensing: Could patients be the answer to the data problem?

4th August 2014

 Adaptive Licensing: Could patients be the answer to the data problem?Articles

Patients could play a key role in generating the data required to make Europe's Adaptive Licensing a success.The timing of patient access to new medicines has always been one of...

Read more

The trend to blend: M&A in pharma - Are you ready?

17th June 2014

 The trend to blend: M&A in pharma - Are you ready?Articles

Paul Gershlick and Laura Barrell examine the recent surge in mergers and acquisitions, and look at what small to medium sized firms can do to make themselves more attractive to...

Read more

UCB looks ahead to next phase

2nd June 2014

 UCB looks ahead to next phaseArticles

As UCB marks 10 years in the UK with a special event at its research centre in Slough, Andrew McConaghie talks to chief executive Roch Doliveux about the company's future.Ten...

Read more

News

AbbVie hits out at US Treasury as Shire bid dies

21st October 2014

 AbbVie hits out at US Treasury as Shire bid dies News

Following AbbVie's recommendation to its shareholders to vote against the takeover of Shire last week, Shire's board has agreed to terminate the Cooperation Agreement and release AbbVie from its obligations...

Read more

AbbVie withdraws Shire bid following US tax changes

16th October 2014

 AbbVie withdraws Shire bid following US tax changesNews

AbbVie's board has recommended its stockholders vote against its proposed £31 billion buyout of Shire as a result of the tightening of US tax laws in September to deter so-called...

Read more

Endo beats QLT to Auxilium merger

10th October 2014

 Endo beats QLT to Auxilium mergerNews

Endo International has persuaded Auxilium Pharma into a takeover that leaves an earlier plan to merge Auxilium with QLT in tatters.Ireland-based Endo has made a $2.6bn cash-and-stock offer for Auxilium...

Read more

US tax inversion clampdown claims a scalp

3rd October 2014

 US tax inversion clampdown claims a scalpNews

Salix Pharmaceuticals has pulled out of its plan to merge with Italy's Cosmo Pharmaceuticals, implying changes to US rules on tax inversion led to the decision.The US drugmaker announced its...

Read more

White Papers

All change for pharma and biotech partnerships

30th September 2013

 All change for pharma and biotech partnershipsWhite Papers

The pharma industry is always evolving, and in the past decade, there has been an increasing reliance on partnering to strengthen R&D. In this original white paper, Phenestra shares its...

Read more

Events

Pharma Logistics Africa

21st October 2014 - 23rd October 2014

Pharma Logistics Africa

IQPC South Africa, in partnership with The Federation of East African Pharmaceutical Manufacturers (FEAPM), is pleased to announce Pharma Logistics Africa 2014, taking place from 21 – 23 October 2014...

Read more

Evidence USA 2014

22nd October 2014 - 23rd October 2014

Evidence USA 2014

Discover how pharma, payers and patients are utilizing real world evidence to understand and demonstrate drug value and improve patient care. These key stakeholders will discuss and debate the pertinent...

Read more

Market Access USA 2014

22nd October 2014 - 23rd October 2014

Market Access USA 2014

Outcomes based payments, competitive health insurance formularies, co pay and Medicaid expansion: learn how to prepare your market access strategy for the ever changing US healthcare market. Understand the diverse...

Read more

2nd International Congress on Paragraph IV Litigation Strategy

29th October 2014 - 30th October 2014

2nd International Congress on Paragraph IV Litigation Strategy

Successful IP Litigation Strategies for Brand Name and Generic Manufacturers Imminent blockbuster patent expiration…new regulatory hurdles and procedural requirements created by the Biologics Price Competition and Innovation and America Invents Act…constantly...

Read more